Evidence map›Paper›PMID 41278904›Full record

ArticlebioRxiv : the preprint server for biology2025

Supervised machine learning identifies impaired mitochondrial quality control in β cells with development of type 2 diabetes.

Mirza Muhammad Fahd Qadir, Charles Dana, Paul Mauvais-Jarvis, Nazmul Haque, Theodore Dos Santos, Patrick E MacDonald, Franck Mauvais-Jarvis

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Mirza Muhammad Fahd QadirTulane Center of Excellence in Sex-based Precision Medicine, New Orleans, LA, USA.ORCID 0000-0002-6764-6151
Charles DanaAlgorithme.ai, Paris, Île-de-France, France.
Paul Mauvais-JarvisAlgorithme.ai, Paris, Île-de-France, France.
Nazmul HaqueTulane Center of Excellence in Sex-based Precision Medicine, New Orleans, LA, USA.
Theodore Dos SantosDepartment of Pharmacology, University of Alberta, Edmonton, AB T6G2R3, Canada.
Patrick E MacDonaldDepartment of Pharmacology, University of Alberta, Edmonton, AB T6G2R3, Canada.
Franck Mauvais-JarvisTulane Center of Excellence in Sex-based Precision Medicine, New Orleans, LA, USA.ORCID 0000-0002-0874-0754

Funding

The Human Islet Distribution Coordinating Center (UC4)UC4DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EVANS-MOLINA, CARMELLA, NILAND, JOYCE CAROL · 2012 to 2017
$25.6M
The Human Pancreas Analysis Program for Type 2 DiabetesU01DK123594 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Robert Babak Faryabi, KLAUS H KAESTNER · 2019 to 2026
$25.0M
Penn integrated Human Pancreas procurement and Analysis ProgramUC4DK112217 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R, FELDMAN, MICHAEL D · 2016 to 2020
$17.8M
Sex-Based Precision Medicine Research CoreP20GM152305 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Yilin X Yoshida · 2024 to 2026
$8.9M
Supplement to Integrated Program for Human Pancreas Procurement and AnalysisUC4DK112232 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ATKINSON, MARK A., POWERS, ALVIN C · 2016 to 2020
$8.4M
Human Pancreas Analysis Program-T2DU01DK123716 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ATKINSON, MARK A., BOTTINO, RITA · 2019 to 2024
$6.6M
Targeting the estrogen receptor-α to protect functional β-cell mass in womenR01DK074970 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI Franck Mauvais-Jarvis · 2007 to 2026
$6.0M
Linking islet cell function and identity from in vitro to in situU01DK120447 · NIDDK · UNIVERSITY OF ALBERTA · PI ARROJO E DRIGO, RAFAEL, LUNDBERG, EMMA · 2018 to 2021
$3.0M
Sex chromosomes and beta-cell functionK99DK140067 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI Mirza Muhammad Fahd Qadir · 2025 to 2026
$179k
BLRD VA I01 BX005812NIDDK NIH HHS K99 DK140067NIDDK NIH HHS R01 DK074970NIDDK NIH HHS U01 DK120447NIDDK NIH HHS U01 DK123594NIDDK NIH HHS U01 DK123716NIDDK NIH HHS UC4 DK098085NIDDK NIH HHS UC4 DK112217NIDDK NIH HHS UC4 DK112232NIGMS NIH HHS P20 GM152305
6 · The paper itself

Abstract

In type 2 diabetes (T2D), molecular pathways driving β cell failure are difficult to resolve with standard single cell analysis. Here we developed an interpretable, supervised machine learning framework that couples sparse rule-based classification (SnakeClassifier), pathway constrained modelling (BlackSwanClassifier), and β cell mitochondrial fitness stratification (Kolmogorov-Arnold Neural Networks KANN), linking and integrating them into disease mechanisms in single cell RNA sequencing (scRNA-seq) from 52 human donors. SnakeClassifier trained on 50 genes accurately predicted T2D at single cell resolution, outperforming classical ensemble machine learning classifier models, and yielded donor level diabetes scores that correlated with chronic hyperglycemia. The clustering of β cell populations (β1-4) revealed a resilient non-diabetic (ND) β1 subtype characterized by preserved β cell identity genes and lower disease risk, whereas T2D β2-4 subtypes exhibited upregulation of genes involved in cellular and mitochondrial stress and suppression of genes promoting oxidative phosphorylation and insulin secretion. Mitophagy emerged as the dominant program linked to T2D and a mitophagy focused BlackSwanClassifier nominated

Indexed as

Disease predictionMachine learningMitophagyRule based classifierType 2 diabetes

Identifiers

PMID41278904
PMCPMC12633212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.